Harmony Biosciences Holdings, Inc. HRMY
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-08-19
Harmony Biosciences Holdings, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 5,835,243 | $176.0M | 9.97% |
| RENAISSANCE TECHNOLOGIES LLC | 1,195,371 | $43.5M | 2.04% |
| TWO SIGMA INVESTMENTS, LP | 959,136 | $34.9M | 1.64% |
| AQR CAPITAL MANAGEMENT LLC | 934,326 | $34.0M | 1.6% |
| MILLENNIUM MANAGEMENT LLC | 319,812 | $11.6M | 0.55% |
| CITADEL ADVISORS LLC | 319,810 | $11.6M | 0.55% |
| Bridgewater Associates, LP | 248,575 | $9.1M | 0.42% |
| D. E. Shaw & Co., Inc. | 52,879 | $1.9M | 0.09% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.